-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Ukraine Conflict Impact Report Overview The large-scale Russian invasion of Ukraine in February 2022 has dramatically restructured strategic priorities within the global defense sector either by developing innovative defense capabilities, or the re-invigorating previously stagnant market segments. As the geostrategic implications of this conflict continue to reverberate across global markets, the primary lesson learned is the need to upscale production capacity and leverage cost-efficiency across all domains of modern warfare, with investments driving innovation of both technology and operations throughout...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRT-1419 in Sarcomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PRT-1419 in Sarcomas Drug Details: PRT-1419 is under development for the treatment of solid tumors,...
-
Sector Analysis
Czech Republic Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Czech Republic Defense Market Report Overview As of 2023, the Czech Republic defense budget was worth $4.7 billion. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 9% between 2024 and 2028. Factors such as the significant changes in the defense and security posture of the Czech Republic as a result of Russia’s 2022 full-scale invasion of Ukraine and expansion of military capability are driving the Czech Republic's defense market growth....
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pirfenidone Sr in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pirfenidone Sr in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Pirfenidone SR in Idiopathic Pulmonary Fibrosis Drug Details:Pirfenidone (EXCL-100) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HB-0036 in Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HB-0036 in Renal Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HB-0036 in Renal Cell Carcinoma Drug Details:HB-0036 a bi-specific antibody is under...
-
Product Insights
Excalibur Field, United Kingdom
Excalibur Field is a producing field located in North Sea, United Kingdom. It is being operated by Perenco Gas (U.K.) Ltd. Empower your strategies with our Excalibur Field, United Kingdom report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Company Profile
MGM Resorts International – Company Profile
MGM Resorts International (MGM Resorts) is a global hospitality company. The company owns and operates casino and non-casino resort projects across the world. Its major business operations include gaming, hospitality, and entertainment activities. The company’s portfolio of destination resorts comprises Aria, Vdara, Bellagio, MGM Grand Las Vegas, Borgata, Empire City, MGM Macau, MGM Cotai, MGM National Harbor, MGM Northfield Park, Mandalay Bay, The Mirage, Luxor, Excalibur, New York-New York, Gold Strike Tunica, MGM Grand Detroit, MGM Springfield, Park MGM, and...
Add to Basket -
Company Profile
MGM Growth Properties LLC – Company Profile
MGM Growth Properties LLC (MGM Growth Properties), a subsidiary of MGM Resorts International, is a real estate investment trust. Its activities include the ownership, acquisition, and leasing of leisure resorts. Its amenities portfolio includes hotel, casino gaming, dining, convention, hospitality, entertainment, and retail offerings. The trust’s properties comprise Mandalay Bay, Park MGM, Gold Strike, Luxor, and Excalibur; The Mirage, The Park, Beau Rivage and Gold Strike Tunica; MGM National Harbor, MGM Grand Detroit, MGM Grand, and others. MGM Growth Properties...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pirfenidone SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pirfenidone SR Drug Details Pirfenidone (EXCL-100) is under development for the treatment of idiopathic...